BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment
Primary and study completion pushed from Sep 2026 to Sep 2027
Memorial Sloan Kettering Cancer CenterPhase 2 NCT04106414 Registry history of NCT04106414 on ClinicalTrials.gov (opens the registry)